Screening assays for compounds that cause apoptosis
    1.
    发明授权
    Screening assays for compounds that cause apoptosis 失效
    导致凋亡的化合物的筛选试验

    公开(公告)号:US07338807B2

    公开(公告)日:2008-03-04

    申请号:US10633789

    申请日:2003-08-04

    IPC分类号: G01N33/00

    摘要: This invention relates to methods of screening for compounds capable of inducing apoptosis in certain tumor cells. The invention also relates to compounds identified by such methods. In addition, the invention relates to methods for the in vitro diagnosis of Xeroderma pigmentosum and compounds useful in these methods.

    摘要翻译: 本发明涉及筛选能够诱导某些肿瘤细胞凋亡的化合物的方法。 本发明还涉及通过这些方法鉴定的化合物。 此外,本发明涉及用于这些方法中有用的皮肤色素调色剂和化合物的体外诊断方法。

    Screening assays for compounds that cause apoptosis
    4.
    发明授权
    Screening assays for compounds that cause apoptosis 失效
    导致凋亡的化合物的筛选试验

    公开(公告)号:US06602979B1

    公开(公告)日:2003-08-05

    申请号:US08359316

    申请日:1994-12-19

    IPC分类号: C07K1400

    摘要: This invention relates to methods of screening for compounds capable of inducing apoptosis in certain tumor cells. The invention also relates to compounds identified by such methods. In addition, the invention relates to methods for the in vitro diagnosis of Xeroderma pigmentosum and compounds useful in these methods.

    摘要翻译: 本发明涉及筛选能够诱导某些肿瘤细胞凋亡的化合物的方法。 本发明还涉及通过这些方法鉴定的化合物。 此外,本发明涉及用于这些方法中有用的皮肤色素调色剂和化合物的体外诊断方法。

    Detection methods based on HR23 protein binding molecules
    5.
    发明授权
    Detection methods based on HR23 protein binding molecules 失效
    基于HR23蛋白结合分子的检测方法

    公开(公告)号:US07820374B2

    公开(公告)日:2010-10-26

    申请号:US10301498

    申请日:2002-11-20

    IPC分类号: C12Q1/68 C12Q1/66 G01N33/53

    摘要: A method is provided for determining whether an agent is capable of inducing a DNA lesion in a eukaryotic cell, including exposing the eukaryotic cell to the agent and determining whether an HR23 protein-binding molecule accumulates in the cell, where the HR23 protein-binding molecule is preferably xeroderma pigmentosum group C (XPC), 3-methyladenine DNA glycosylase (MAG), CREB, p53, or a functional part, derivative, and/or analogue thereof. Preferably the cell overexpresses HR23A and/or HR23B protein. A rapid and sensitive test is provided with significant advantages over the Ames test. A method is provided for determining whether an agent is capable of inhibiting a cellular process, the process resulting in accumulation of HR23 protein-binding molecule within a cell. A method for determining whether a cell has an impaired DNA repair system is provided. An impaired DNA repair system is indicative for diseases such as xeroderma pigmentosum, cockayne syndrome, and/or trichothiodystrophy.

    摘要翻译: 提供了一种用于确定试剂是否能够诱导真核细胞中的DNA损伤的方法,包括将真核细胞暴露于所述试剂并确定HR23蛋白结合分子是否累积在细胞中,其中HR23蛋白结合分子 优选皮肤色素性组C(XPC),3-甲基腺嘌呤DNA糖基化酶(MAG),CREB,p53或其功能部分,衍生物和/或类似物。 细胞优选过表达HR23A和/或HR23B蛋白。 与Ames测试相比,提供了一个快速灵敏的测试。 提供了一种用于确定试剂是否能够抑制细胞过程的方法,所述方法导致HR23蛋白结合分子在细胞内的积累。 提供了确定细胞是否具有受损的DNA修复系统的方法。 受损的DNA修复系统指示诸如色素性皮炎,cockayne综合征和/或毛状体营养不良的疾病。